levofloxacin has been researched along with Lung Diseases in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (33.33) | 29.6817 |
| 2010's | 8 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dudley, MN; Griffith, DC; Miller, CE; Nolan, TG; Sabet, M; Senekeo-Effenberger, K | 1 |
| Burns, JL; Dudley, MN; Griffith, DC; King, P; Lomovskaya, O | 1 |
| Gupta, PV; Nagarsenker, MS; Nirwane, AM | 1 |
| Chang, LW; Chang, YT; Cheng, SL; Chuang, YC; Hsu, MC; Perng, WC; Tsao, SM; Wu, RG | 1 |
| Asano, F; Masuda, A; Matsumoto, S; Matsuno, Y; Murakami, A; Sobajima, T; Tsuzuku, A | 1 |
| Babarina, MB; Sokolova, VI; Sychev, DA; Zaikov, DA | 1 |
| Hashiguchi, N; Inoshima, I; Inoshima, N | 1 |
| Edell, ES; Kern, RM; Maldonado, F; Midthun, DE; Skalski, JH | 1 |
| Baquero, F; Cantón, R; Fernández-Olmos, A; García-Castillo, M; Lamas, A; Maiz, L | 1 |
| Carosi, G; Casari, S; Chiodera, A; Moretti, F; Quiros-Roldan, E; Viale, P | 1 |
| Coker, A; Coker, C; Erkan, N; Onek, T; Sağol, O; Zeytunlu, M | 1 |
| Amado, J; Carvalho, A; Ferreira, Dde F; Neves, S; Nogueira, R; Taveira, N | 1 |
1 trial(s) available for levofloxacin and Lung Diseases
| Article | Year |
|---|---|
Integrated safety summary of phase II and III studies comparing oral nemonoxacin and levofloxacin in community-acquired pneumonia.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; China; Community-Acquired Infections; Double-Blind Method; Drug Combinations; Female; Fluoroquinolones; Humans; Levofloxacin; Lung Diseases; Male; Middle Aged; Pneumonia; Quinolones; Safety; South Africa; Taiwan; Treatment Outcome; Young Adult | 2019 |
11 other study(ies) available for levofloxacin and Lung Diseases
| Article | Year |
|---|---|
Efficacy of aerosol MP-376, a levofloxacin inhalation solution, in models of mouse lung infection due to Pseudomonas aeruginosa.
Topics: Administration, Inhalation; Aerosols; Animals; Anti-Bacterial Agents; Aztreonam; Disease Models, Animal; Female; Levofloxacin; Lung Diseases; Mice; Microbial Sensitivity Tests; Ofloxacin; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin | 2009 |
In vitro pharmacodynamics of levofloxacin and other aerosolized antibiotics under multiple conditions relevant to chronic pulmonary infection in cystic fibrosis.
Topics: Aerosols; Anti-Bacterial Agents; Bacteria; Biofilms; Chronic Disease; Ciprofloxacin; Colony Count, Microbial; Cystic Fibrosis; Humans; Levofloxacin; Lung Diseases; Microbial Sensitivity Tests; Ofloxacin; Sputum | 2010 |
Inhalable Levofloxacin Liposomes Complemented with Lysozyme for Treatment of Pulmonary Infection in Rats: Effective Antimicrobial and Antibiofilm Strategy.
Topics: Administration, Inhalation; Animals; Anti-Bacterial Agents; Biofilms; Drug Therapy, Combination; Levofloxacin; Liposomes; Lung Diseases; Muramidase; Rats; Respiratory Tract Infections; Staphylococcal Infections; Staphylococcus aureus | 2018 |
A Case of Pulmonary Actinomycosis Associated With Aspiration of Cedar Leaves.
Topics: Actinomyces; Actinomycosis; Anti-Bacterial Agents; Biopsy; Bronchoscopy; Cedrus; Clarithromycin; Female; Foreign Bodies; Humans; Levofloxacin; Lung Abscess; Lung Diseases; Middle Aged; Rare Diseases; Tomography, X-Ray Computed | 2015 |
[Prospects of Levofloxacin Use in Therapy of Patients with Bronchopulmonary Diseases or Skin and Soft Tissue Pyo-Inflammatory Lesions].
Topics: Adult; Anti-Bacterial Agents; Bronchitis; Dose-Response Relationship, Drug; Female; Humans; Levofloxacin; Lung Diseases; Male; Microbial Sensitivity Tests; Middle Aged; Pneumonia, Bacterial; Severity of Illness Index; Skin Diseases, Bacterial; Soft Tissue Infections; Treatment Outcome; Tuberculosis, Pulmonary; Young Adult | 2014 |
[A CASE OF PULMONARY MYCOBACTERIUM ABSCESSUS INFECTION SUCCESSFULLY TREATED WITH SHORT-TERM CAM, AMK, AND IPM/cs FOLLOWED BY LONG-TERM ORAL CAM AND LVFX].
Topics: Administration, Oral; Aged; Amikacin; Anti-Bacterial Agents; Cilastatin; Cilastatin, Imipenem Drug Combination; Clarithromycin; Drug Combinations; Female; Humans; Imipenem; Levofloxacin; Lung Diseases; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria | 2015 |
Pulmonary Abscess as a Complication of Transbronchial Lung Cryobiopsy.
Topics: Anti-Bacterial Agents; Biopsy; Bronchoscopy; Humans; Levofloxacin; Lung; Lung Abscess; Lung Diseases; Male; Metronidazole; Middle Aged; Tomography, X-Ray Computed | 2016 |
In vitro prevention of Pseudomonas aeruginosa early biofilm formation with antibiotics used in cystic fibrosis patients.
Topics: Bacterial Typing Techniques; Biofilms; Ciprofloxacin; Cystic Fibrosis; Female; Humans; Levofloxacin; Lung Diseases; Male; Microbial Sensitivity Tests; Ofloxacin; Pseudomonas aeruginosa; Pseudomonas Infections | 2012 |
Rhodococcus equi: pulmonary cavitation lesion in patient infected with HIV cured by levofloxacin and rifampicin.
Topics: Actinomycetales Infections; Adult; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Anti-Infective Agents; Drug Therapy, Combination; HIV Infections; Humans; Levofloxacin; Lung Diseases; Male; Ofloxacin; Rhodococcus equi; Rifampin | 2002 |
Effects of selected antibiotics on pancreatitis induced liver and pulmonary injury.
Topics: Acute Disease; Alanine Transaminase; Amylases; Animals; Anti-Bacterial Agents; Aspartate Aminotransferases; Imipenem; L-Lactate Dehydrogenase; Levofloxacin; Liver; Liver Diseases; Lung; Lung Diseases; Male; Nitric Oxide; Ofloxacin; Pancreatitis; Rats; Rats, Wistar | 2005 |
Treatment of pulmonary actinomycosis with levofloxacin.
Topics: Actinomycosis; Anti-Bacterial Agents; Diagnosis, Differential; Female; Humans; Levofloxacin; Lung Diseases; Lung Neoplasms; Middle Aged; Ofloxacin; Tomography, X-Ray Computed | 2008 |